Nuveen Asset Management, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,924,204
-62.1%
205,358
-0.7%
0.00%
-50.0%
Q2 2023$5,071,234
+70677.9%
206,736
-32.9%
0.00%
-33.3%
Q1 2023$7,165
-42.7%
307,923
-37.6%
0.00%
-40.0%
Q4 2022$12,496
-99.9%
493,722
-12.8%
0.01%
+25.0%
Q3 2022$10,919,000
-35.7%
566,381
-15.0%
0.00%
-42.9%
Q2 2022$16,969,000
-15.3%
666,227
-15.7%
0.01%
+16.7%
Q1 2022$20,028,000
-22.9%
790,664
+27.5%
0.01%
-25.0%
Q4 2021$25,963,000
+78.2%
620,065
+85.2%
0.01%
+100.0%
Q3 2021$14,569,000
+30.4%
334,765
+41.7%
0.00%
+33.3%
Q2 2021$11,170,000
-5.7%
236,245
+2.2%
0.00%
-25.0%
Q1 2021$11,850,000
+89.1%
231,127
-1.2%
0.00%
+100.0%
Q4 2020$6,265,000
-44.6%
233,941
-29.0%
0.00%
-50.0%
Q3 2020$11,316,000
+21.8%
329,648
+45.4%
0.00%0.0%
Q2 2020$9,287,000
+638.8%
226,677
+517.6%
0.00%
+300.0%
Q1 2020$1,257,000
+779.0%
36,704
+223.7%
0.00%
Q4 2019$143,00011,3400.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders